Financhill
Buy
53

VRTX Quote, Financials, Valuation and Earnings

Last price:
$462.94
Seasonality move :
7.07%
Day range:
$457.04 - $461.49
52-week range:
$362.50 - $519.68
Dividend yield:
0%
P/E ratio:
32.36x
P/S ratio:
10.14x
P/B ratio:
6.73x
Volume:
768.5K
Avg. volume:
1.5M
1-year change:
13.31%
Market cap:
$116.5B
Revenue:
$11B
EPS (TTM):
$14.19

Earnings Data

Next earnings date for VRTX
Feb 09
2026
Most recent earnings per share
$4.20
Missed by $0.37
(Nov 3/2025)
Consensus Estimate
$4.58
(Nov 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VRTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/09/2026 Q4 $3.2B -- -- $5.17 --
11/03/2025 Q3 $3.1B $3.1B $4.20 $4.58 -$0.37
08/04/2025 Q2 $2.9B $3B $3.99 $4.25 -$0.26
05/05/2025 Q1 $2.9B $2.7B $2.49 $4.29 -$1.80
02/10/2025 Q4 $2.8B $2.9B $3.50 $4.02 -$0.52
11/04/2024 Q3 $2.7B $2.8B $4.01 $4.13 -$0.13
08/01/2024 Q2 $2.7B $2.6B -$13.92 -$11.75 -$2.17
05/06/2024 Q1 $2.6B $2.7B $4.21 $4.06 $0.15
02/05/2024 Q4 $2.5B $2.5B $3.71 $4.09 -$0.37
11/06/2023 Q3 -- $2.5B $3.97 -- --
08/01/2023 Q2 -- $2.5B $3.52 -- --
05/01/2023 Q1 -- $2.4B $2.69 -- --
02/07/2023 Q4 -- $2.3B $3.15 -- --
10/27/2022 Q3 -- $2.3B $3.59 -- --
08/04/2022 Q2 -- $2.2B $3.13 -- --
05/05/2022 Q1 -- $2.1B $2.96 -- --
01/26/2022 Q4 -- $2.1B $3.00 -- --
11/02/2021 Q3 -- $2B $3.28 -- --
07/29/2021 Q2 -- $1.8B $0.26 -- --
04/29/2021 Q1 -- $1.7B $2.49 -- --
02/01/2021 Q4 -- $1.6B $2.30 -- --
10/29/2020 Q3 -- $1.5B $2.53 -- --
07/30/2020 Q2 -- $1.5B $3.18 -- --
04/29/2020 Q1 -- $1.5B $2.29 -- --
01/30/2020 Q4 -- $1.4B $2.23 -- --
10/30/2019 Q3 -- $939.5M $0.22 -- --
07/31/2019 Q2 -- $933.1M $1.03 -- --
04/30/2019 Q1 -- $851.6M $1.03 -- --
02/05/2019 Q4 -- $863.9M $5.97 -- --
10/24/2018 Q3 -- $782.8M $0.50 -- --
07/25/2018 Q2 -- $754.8M $0.80 -- --
04/26/2018 Q1 -- $640.8M $0.81 -- --
01/31/2018 Q4 -- $651.6M $0.39 -- --
10/25/2017 Q3 -- $578.2M -$0.41 -- --
07/26/2017 Q2 -- $542.2M $0.07 -- --
04/27/2017 Q1 -- $714.7M $0.99 -- --
01/25/2017 Q4 -- $458.7M $0.13 -- --
10/25/2016 Q3 -- $413.8M -$0.16 -- --
07/27/2016 Q2 -- $431.6M -$0.26 -- --
04/27/2016 Q1 -- $398.1M -$0.17 -- --
01/27/2016 Q4 -- $417.9M -$0.31 -- --

Vertex Pharmaceuticals, Inc. Earnings Questions

  • How Much did Vertex Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Vertex Pharmaceuticals, Inc. reported $3.1B worth of top line sales in its most recent quarter.

  • Did Vertex Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Vertex Pharmaceuticals, Inc. announced earnings per share of $4.20 which represents a miss of analyst forecast a $4.58 per share.

  • Is Vertex Pharmaceuticals, Inc. Profitable?

    Vertex Pharmaceuticals, Inc. reported $2.7B that represents $10.48 per share over the last quarter.

  • What is the Analyst Consensus for Vertex Pharmaceuticals, Inc. EPS Next Year?

    Vertex Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$2.08 per share to $0.49 per share next year representing a decrease of -96.5%.

  • When is Vertex Pharmaceuticals, Inc.'s Earnings Date?

    Vertex Pharmaceuticals, Inc.'s next earnings date is February 9, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock